Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K H Antonin

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|June 1, 1977
Pharmacokinetics and bioavailability of sodium valproateU Klotz, K H Antonin
International Journal of Clinical Pharmacology and Biopharmacy|July 1, 1977
Biliary excretion studies with digoxin in manU Klotz, K H Antonin
Versicherungsmedizin|March 26, 2003
[Significance of environmental medicine from the viewpoint of the medical review board of the social health insurance program]K H Antonin, B Burkhard
Zeitschrift Fur Gastroenterologie|March 1, 1984
Glucagon-induced alterations of plasma levels of cyclic AMP and glucose in patients with liver diseaseU Klotz, K H Antonin
Journal of Clinical Psychopharmacology|August 1, 1988
Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjectsP R Bieck, K H Antonin
Journal of Neural Transmission. Supplementum|January 1, 1989
Tyramine potentiation during treatment with MAO inhibitors: brofaromine and moclobemide vs irreversible inhibitorsP R Bieck, K H Antonin
Gut|December 1, 1987
Transdermal scopolamine and gastric acid secretionK H Antonin, P R Bieck
European Journal of Clinical Pharmacology|January 1, 1982
Monoamine oxidase inhibition by tranylcypromine: assessment in human volunteersP R Bieck, K H Antonin
Modern Problems of Pharmacopsychiatry|January 1, 1983
Monoamine oxidase inhibition in healthy volunteers by CGP 11305 A, a new specific inhibitor of MAO-AP Bieck, K H Antonin, M Jedrychowski
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1975
Proceedings: Pharmacokinetics and protein binding of diazepam in man and different speciesU Klotz, K H Antonin, P Bieck
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|June 1, 1977
Pharmacokinetics and bioavailability of sodium valproateU Klotz, K H Antonin
International Journal of Clinical Pharmacology and Biopharmacy|July 1, 1977
Biliary excretion studies with digoxin in manU Klotz, K H Antonin
Versicherungsmedizin|March 26, 2003
[Significance of environmental medicine from the viewpoint of the medical review board of the social health insurance program]K H Antonin, B Burkhard
Zeitschrift Fur Gastroenterologie|March 1, 1984
Glucagon-induced alterations of plasma levels of cyclic AMP and glucose in patients with liver diseaseU Klotz, K H Antonin
Journal of Clinical Psychopharmacology|August 1, 1988
Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjectsP R Bieck, K H Antonin
Journal of Neural Transmission. Supplementum|January 1, 1989
Tyramine potentiation during treatment with MAO inhibitors: brofaromine and moclobemide vs irreversible inhibitorsP R Bieck, K H Antonin
Gut|December 1, 1987
Transdermal scopolamine and gastric acid secretionK H Antonin, P R Bieck
European Journal of Clinical Pharmacology|January 1, 1982
Monoamine oxidase inhibition by tranylcypromine: assessment in human volunteersP R Bieck, K H Antonin
Modern Problems of Pharmacopsychiatry|January 1, 1983
Monoamine oxidase inhibition in healthy volunteers by CGP 11305 A, a new specific inhibitor of MAO-AP Bieck, K H Antonin, M Jedrychowski
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1975
Proceedings: Pharmacokinetics and protein binding of diazepam in man and different speciesU Klotz, K H Antonin, P Bieck
Pageof 5